Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol-Reference-Cited by-同舟云学术

Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol

Published:2017-12 Issue:1 Volume:8 Page:1-3
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

LeVarge Barbara L.¹,Law Anica C.²,Murphy Blanche³

Affiliation:

1. Pulmonary Diseases and Critical Care MedicineUniversity of North CarolinaChapel HillNCUSA

2. Pulmonary, Critical Care, and Sleep MedicineBeth Israel Deaconess Medical CenterBostonMAUSA

3. Central Line ServiceBeth Israel Deaconess Medical CenterBostonMAUSA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045893217748054

Reference19 articles.

1. Long‐term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival;Sitbon O;J Am Coll Cardiol,2002

2. Long‐term survival of patients with pulmonary arterial hypertension recovering to World Health Organization functional class I or II: a historical comparison between intravenous epoprostenol and oral agents;Yamamoto K;BMC Res Notes,2014

3. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications);Pittiruti M;Clin Nutr,2009

4. Renal Association Clinical Practice Guideline on vascular access for haemodialysis;Fluck R;Nephron Clin Pract,2011

5. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access;National Kidney Foundation;Am J Kidney Dis,2006

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epoprostenol;Reactions Weekly;2018-02